Seroconversion after coronavirus disease 2019 vaccination in patients with immune deficiency.

Squire, Jacqueline; Joshi, Avni

Squire, Jacqueline; Joshi, Avni.

Squire J; Division of Pulmonary, Allergy, and Sleep Medicine, Department of Medicine, Mayo Clinic, Jacksonville, Florida.
Joshi A; Division of Allergic Diseases, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota. Electronic address: joshi.avni@mayo.edu.

Ann Allergy Asthma Immunol ; 127(3): 383-384, 2021 09.

Article in English | MEDLINE | ID: covidwho-1267586

Subject(s)

Antibodies, Viral/biosynthesis; COVID-19 Vaccines/administration & dosage; COVID-19/prevention & control; Immunity, Humoral/drug effects; Immunologic Deficiency Syndromes/drug therapy; Seroconversion; Adult; Aged; COVID-19/immunology; Female; Humans; Immunity, Cellular/drug effects; Immunoglobulins, Intravenous/therapeutic use; Immunologic Deficiency Syndromes/immunology; Immunologic Deficiency Syndromes/pathology; Male; Middle Aged; Retrospective Studies; SARS-CoV-2/immunology; Vaccination/methods

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Immunity, Humoral / Seroconversion / COVID-19 Vaccines / COVID-19 / Immunologic Deficiency Syndromes / Antibodies, Viral Type of study: Observational study Topics: Vaccines Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google